Health Risks of an Inactive Lifestyle
Also known as: Sedentary lifestyle, Sitting disease
Methodology & AI Transparency ⓘ
Health Risks of an Inactive Lifestyle Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is an inactive lifestyle? Being a couch potato.
- 2 Real-world patient consensus: Diagnostic registry E65.1: Health Risks of an Inactive Lifestyle is managed within Weight & Metabolism (aka Sedentary lifestyle).
- 3 Typical cash cost range: Primary evaluation for Health Risks of an Inactive Lifestyle incorporates fasting cardiometabolic panels [Health Risks of an Inactive Lifestyle E65.1] and symptom diary review.
- 4 Top reported side effects / signs: Key Weight & Metabolism biomarkers for Health Risks of an Inactive Lifestyle (E65.1): HOMA-IR Insulin Resistance in Health Risks of an Inactive Lifestyle (E65.1: Index) & ALT & Fasting in Health Risks of an Inactive Lifestyle (E65.1: Triglycerides) (ALT < 25 U/L; TG < 100 mg/dL (E65.1)).
Ask our AI Specialists anything about Health Risks of an Inactive Lifestyle
What Is Health Risks of an Inactive Lifestyle?
What is an inactive lifestyle? Being a couch potato. Not exercising. A sedentary or inactive lifestyle. These all mean the same thing: a lifestyle with a lot of sitting and lying down, with very little or no exercise. People are spending more time doing sedentary activities. During our leisure time, we are often sitting while using a computer or other device, watching TV, or playing video games. Many of our jobs have become more sedentary, with long days sitting at a desk or while commuting. And the way most of us get around involves sitting - in cars, on buses, and on trains.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Health Risks of an Inactive Lifestyle (E65.1, Weight & Metabolism) reflects TNF-alpha) [Health Risks of an Inactive Lifestyle E65.1]. Cross-referenced with NIH MeSH (Sedentary Behavior), longitudinal control is benchmarked via HOMA-IR Insulin Resistance in Health Risks of an Inactive Lifestyle (E65.1: Index).
Common Symptoms & Clinical Signs
- • You burn fewer calories. This makes you more likely to gain weight
- • You may lose muscle strength and endurance, because you are not using your muscles as much
- • Presentation of Health Risks of an Inactive Lifestyle (E65.1): persistent hunger signaling [Health Risks of an Inactive Lifestyle E65.1]
- • Secondary Health Risks of an Inactive Lifestyle clinical sign: co-existing blood pressure, in Health Risks of an Inactive Lifestyle (E65.1: triglyceride, or fasting)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Health Risks of an Inactive Lifestyle Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | E65.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Weight Management & Metabolic Syndrome | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: HOMA-IR Insulin Resistance in Health Risks of an Inactive Lifestyle (E65.1: Index) | < 1.4 (E65.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: ALT & Fasting in Health Risks of an Inactive Lifestyle (E65.1: Triglycerides) | ALT < 25 U/L; TG < 100 mg/dL (E65.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: DEXA Visceral Adipose in Health Risks of an Inactive Lifestyle (E65.1: Tissue (VAT)) | < 1.0 lb (< 100 cm2) (E65.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Health Risks of an Inactive Lifestyle
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Ibuprofen Childrens Advil, Childrens Flanax Oral • RxCUI 197805 | Nonsteroidal Anti-inflammatory Drug | 78% | $0.0345 | $ 5.53 /mo |
| Tolmetin Sodium Tolectin, Tolectin DS • RxCUI 198297 | Nonsteroidal Anti-inflammatory Drug | 94% | $2.8800 | $ 114.21 /mo |
| Salsalate Salsalate Generic • RxCUI 312899 | FDA Prescription Therapeutic Agent | 77% | $0.2153 | $ 17.22 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Health Risks of an Inactive Lifestyle)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Check Your Medicine Cabinet: FDA Enforcement Recall D-0042-2027 (Class II): Metoclopramide Tablets, USP, 5 mg, 100 Ta Reason for Recall (Class II): Presence of Foreign Tablets/Capsules openFDA Drug Enforcement & Recall Registry • 2026-10-21 • FDA Drug Recall (Class II) | Multi-cohort | 96/100 | PMID FDARECALL-D-0042-2027 ↗ |
| New Insights on Immunogenicity and safety of a quadrivalent high-dose inactivated influenza: What a 1,528-Participant Study Found IIV4-HD provided superior immunogenicity versus IIV4-SD and was well tolerated in adults aged ≥60 y. Human vaccines & immunotherapeutics • 2021-12-02 • Phase III Randomized Trial | N = 1,528 | 96/100 | PMID 34714720 ↗ |
| New Insights on Reductions in acute medication use and healthcare resource utilization in: What a 1,113-Participant Study Found Treatment with galcanezumab resulted in significant reductions in headache medication overuse and migraine headache days requiring acute medication use, with notable reductions in migraine-specific HCRU. Journal of medical economics • 2022-01-15 • Phase III Randomized Trial | N = 1,113 | 96/100 | PMID 35971655 ↗ |
| New Insights on Immunogenicity, safety, and lot consistency of the anthrax vaccine adsorbed,: What a 3,689-Participant Study Found The study met the pre-defined endpoint criteria, demonstrating protective level of immune response and non-inferiority of CYFENDUS to BioThrax vaccination. Vaccine • 2026-02-06 • Phase III Randomized Trial | N = 3,689 | 96/100 | PMID 41401704 ↗ |
| Check Your Medicine Cabinet: FDA Enforcement Recall D-0006-2027 (Class II): Sterile Lubricant Dry Eye Relief Eye Drop Reason for Recall (Class II): Lack of Assurance of Sterility openFDA Drug Enforcement & Recall Registry • 2026-10-14 • FDA Drug Recall (Class II) | Multi-cohort | 96/100 | PMID FDARECALL-D-0006-2027 ↗ |
Health Risks of an Inactive Lifestyle Patient Community & “People Like Me” Threads
Filter Health Risks of an Inactive Lifestyle community threads and patient logs by age, biological sex, dosage, and treatment duration.